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Tea, made from the leaves of Camellia sinensis, is a popular 
beverage consumed worldwide. Historically, tea has been used for 
thousands of years as a medicinal herb and was also used widely 
as a beverage starting from the Tang and Song Dynasties. In the 
Cha Jing (Tea Bible) by Lu Yu of Tang Dynastya, the produc‑
tion of tea, the water and utensils used in the preparation of the 
tea beverage, and the possible health effects were described in 
detail. Tea was formally considered as a medicine in the Xin Xiu 
Ben Cao of the Tang Dynastyb. Tea was described as “… bitter 
and sweet, slightly cold and with no toxicity. It has the functions 
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ABSTRACT
Green tea (綠茶 Lǜ Chá), made from the leaves of the plant Camellia sinensis, has traditionally been used as a medicine in China for 
thousands of years. According to the classical work of Li Shizhen (李時珍 Lǐ Shí Zhēn) of the Ming Dynasty, “tea is cold and lowers 
the fire.” Since fire (inflammation) causes many diseases, could tea be effective in the prevention of many diseases? The possible 
prevention of chronic diseases such as cancer, metabolic syndrome, obesity, diabetes, and cardiovascular diseases has been studied 
with contemporary scientific methods, and the results are promising. The molecular mechanisms underlining these observations will be 
discussed in this presentation. One of the reasons for the failure to demonstrate a disease‑preventive effect of tea in some epidemiological 
studies is the lower quantities of tea consumption in humans. Can we increase the quantity of tea consumption to harness its health 
benefits without causing gastrointestinal irritation? This is a topic for further research.
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of pushing down the perverse rising qi; eliminating thirst, heat 
and phlegm; diuretic, shortening of sleeping time, and…”b. In 
the classical Ben Cao Gang Mu (本草綱目 Běn Cǎo Gāng Mù) 
by Li Shizhen (李時珍 Lǐ Shí Zhēn) of the Ming Dynasty, “Tea, 
bitter and cold … is strongly anti‑inflammatory. Inflammation is 
the cause of many diseases.”c. In modern medicine, it is also now 
recognized that inflammation is a causative or contributing factor 
to many diseases. If tea has anti‑inflammatory activity, can it help 
to prevent many diseases?
An important aspect of Traditional Chinese Medicine (TCM) 
is the concept of preventing diseases before their manifestation; 
this is similar to modern preventive medicine. However, modern 
preventive medicine, unlike TCM, does not rely on classical litera‑
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ture; it is based on evidence from experiments in animal models 
and cell lines, human epidemiology studies, and clinical trials. 
For the past 25 years, tea has been studied for its beneficial health 
effects. These include the reduction of body weight, alleviation 
of metabolic syndrome (MetS), and prevention of cardiovascular 
diseases (CVDs), cancer, and neurodegeneration. Results on 
its promising beneficial health effects when tea is consumed in 
sufficient quantities are emerging, and this topic was recently 
reviewed.[1] Did Li Shizhen, the grandmaster of TCM, have the 
insight that took 450 years for modern medicine to discern? Or 
are we interpreting his simple statement more deeply than he 
intended? What useful information can we obtain from classic 
TCM literature? These are topics for discussion.
CVDs and cancer are the two most common diseases in modern 
society. Obesity and diabetes are emerging as major health issues, 
and the closely related MetS also predisposes individuals to CVDs. 
If tea could prevent or delay the development of these diseases, the 
public health implications would be tremendous. Because of this, 
there is great public interest in this area of research. This article 
provides a critical review of these topics, discusses the possible 
common mechanisms involved, and evaluates the human relevance 
of the published health effects.
CHEMISTRY OF TEA CONSTITUENTS
The classical tea is believed to be mainly green tea (綠茶 Lǜ Chá). 
In the manufacturing of green tea, the tea leaves are steamed or 
baked, rolled, and dried. The heating and drying of the tea leaves 
help to stabilize the tea constituents during storage. Green tea pos‑
sesses characteristic polyphenolic compounds known as catechins, 
which include: (−)‑epigallocatechin‑3‑gallate (EGCG), (−)‑epigal‑
locatechin (EGC), (−)‑epicatechin‑3‑gallate (ECG), and (−)‑epi‑
catechin (EC). The structures of catechins together with theanine 
are shown in Figure 1. Catechins account for about 30‑42% of 
the dry weight of brewed green tea, and EGCG is the major form 
of tea catechins. Tea leaves also contain lower quantities of other 
polyphenols, such as quercetin, kaempferol, and myricetin, as well 
as alkaloids such as caffeine and theobromine. A typical brewed 
green tea beverage (e.g. 2.5 g tea leaves in 250 ml of hot water) 
usually contains 240‑320 mg of catechins, of which 60‑65% is 
EGCG and 20‑50 mg is caffeine.[2,3] In the manufacturing of black 
tea (紅茶 Hóng Chá), the tea leaves are withered and crushed to 
cause enzyme‑mediated oxidation in a process commonly referred 
to as “fermentation.” During this process, most of the catechins are 
oxidized, oligomerized, and polymerized to form theaflavins and 
thearubigins, which provide the red‑brown color of black tea.[2,3] 
In brewed black tea, catechins, theaflavins, and thearubigins each 
account for 3‑10%, 2‑6%, and greater than 20% of the dry weight, 
respectively. The caffeine contents in black tea are the same as in 
green tea. Oolong tea is manufactured by crushing only the rims 
of the leaves and limiting fermentation to a short period of time to 
produce the tea’s specific flavor and taste. Generally, oolong tea 
contains catechins, theaflavins, and thearubigins, as well as some 
characteristic components such as epigallocatechin esters, theasi‑
nensins, dimeric catechins, and dimeric proanthocyanidins.[3] The 
contents of theanine, a characteristic amino acid in tea, vary with 
conditions of cultivation and manufacturing of tea.
Tea catechins and other tea polyphenols are strong antioxi‑
Figure 1. The structures of tea catechins and l‑theanine (from [1])
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dants, efficiently scavenging free radicals.[3] Tea polyphenols also 
have a high affinity to bind metals, preventing metal ion–induced 
formation of reactive oxygen species (ROS).[2,3] The phenolic 
groups in catechins can be donors for hydrogen bonding. Hy‑
drogen bonding of a catechin molecule to water forms a large 
hydration shell. This hydrogen bonding capacity also enables 
tea polyphenols to bind strongly to proteins, lipids, and nucleic 
acids. For example, EGCG is known to bind to serum proteins 
such as fibronectin, fibrinogen, and histidine‑rich glycoproteins. 
More recently, EGCG has been shown to bind strongly to 67‑kDa 
laminin receptor, B‑cell lymphoma 2 (Bcl‑2) proteins, vimentin, 
and peptidyl prolyl cis/trans isomerase (PIN1), and these proteins 
have been proposed to be the targets of EGCG for anti‑cancer 
activities. (reviewed in [4,5]) Black tea polyphenols may bind to 
biomolecules and biomembranes to a greater degree than EGCG.
BIOAVAILABILITY AND 
BIOTRANSFORMATION OF TEA 
CONSTITUENTS
According to Lipinski’s rule of five,[6] compounds that have 
5 or more hydrogen bond donors, 10 or more hydrogen bond ac‑
ceptors, a molecular weight greater than 500, and a Log P greater 
than 5 are usually poorly absorbed following oral administration. 
This is due to their large actual size (high molecular weight), 
large apparent size (formation of a large hydration shell), and 
high polarity.[6] The bioavailabilities of tea polyphenols follow 
this prediction. (reviewed in[7,8]) EGCG and other tea catechins 
undergo extensive biotransformation. (reviewed in [3]) Because 
of their catechol structure, EGCG and other catechins are readily 
methylated by catechol‑O‑methyltransferase. In addition, catechins 
are also glucuronidated by UDP‑glucuronosyltransferases and 
sulfotransferases. Multiple methylation and conjugation reactions 
can occur on the same molecule.[3] Active efflux has been shown 
to limit the bioavailability of many polyphenolic compounds. The 
multidrug resistance‑associated protein 2 (MRP2), located on the 
apical surface of the intestine and liver, mediates the transport 
of some polyphenolic compounds to the lumen and bile, respec‑
tively.[9] Therefore, EGCG and its conjugates are predominantly 
effluxed from the enterocytes into the intestinal lumen, or effluxed 
from the liver to the bile and excreted in the feces, and little to none 
of these compounds are present in the urine. Tea catechins can be 
degraded in the intestinal tract by microorganisms to ring fission 
metabolites with valerolactone structures, which can be found in 
human urine and plasma samples several hours after the ingestion 
of tea.[10] These compounds can undergo further degradation to 
phenylacetic and phenylpropionic acids.[3]
TEA AND CANCER PREVENTION
Cancer is a major disease worldwide and is the most common 
or second most common cause of death in many countries. The 
question of whether tea consumption can prevent cancer has drawn 
great attention of researchers and the general public. Cancer is a 
disease that involves a series of genetic and epigenetic changes 
over a relatively long period of time, from 10 to 40 years. In theory, 
if the constituents of tea can block some of the molecular changes 
in the process of cancer formation, the onset of this disease can be 
prevented or delayed. In fact, this has been demonstrated in many 
animal models during the past 20 years. For example, when experi‑
mental mice were injected with cancer‑causing substances isolated 
from cigarettes or cigarette smoke, almost all the mice developed 
lung tumors in 15‑20 weeks. If we put tea extracts in the drinking 
water, the number of tumors formed would be significantly smaller 
in the mice drinking it than the number in the mice that drink 
water without the additional tea extract. In fact, tea and its major 
constituents have been demonstrated to inhibit tumorigenesis in 
many animal models for different organ sites, including the lung, 
oral cavity, esophagus, stomach, small intestine, colon, skin, liver, 
pancreas, bladder, prostate, and mammary glands.[5] Most of the 
studies were conducted with green tea (綠茶 Lǜ Chá), green tea 
polyphenol preparations, or pure EGCG, the major and the most ac‑
tive constituent in tea, administered through drinking water or diet.[5]
In contrast to the strong evidence for the cancer‑preventive 
activities of tea constituents in animal models, results from 
epidemiological studies have not been consistent in demonstrat‑
ing the cancer‑preventive effect of tea consumption in humans 
(reviewed in [1]). A recent comprehensive review by Yuan et al.,[11] 
concluded that after adjusting for confounding factors, consump‑
tion of green tea was frequently associated with a reduced risk of 
upper gastrointestinal tract cancers and limited data supported its 
protective effect against lung and hepatocellular cancer. However, 
intake of black tea (紅茶 Hóng Chá) was generally not associated 
with a lower risk of cancer.[11,12]
The disparity in results between animal and human studies, 
observed not only in cancer prevention but also in the prevention 
of other diseases, is likely due to the lower quantities of human 
tea consumption as compared to the doses used in animal studies, 
as well as the many potential confounding factors involved in 
epidemiological studies. In humans, many lifestyles, genetic poly‑
morphisms, and other confounding factors may reduce the power 
of epidemiological studies for detecting a cancer‑preventive effect. 
Smoking appears to be a strong confounding factor. For example, 
in a case–control study on the effect of green tea consumption 
on esophageal cancer in Shanghai, a protective effect was only 
observed in women who were mostly nonsmokers.[13] Similarly, in 
the Shanghai Men’s Health Study, green tea drinking was found to 
reduce the risk of colorectal cancer among nonsmoking men, but 
not in men in general.[14] In a recent large‑scale, population‑based 
case–control study in urban Shanghai, regular green tea drink‑
ing was associated with a 32% reduction of pancreatic cancer 
risk (compared to those who did not drink tea regularly) in women 
who were mostly nonsmokers.[15] Such a beneficial effect of tea 
drinking, however, was not observed in men who were mostly 
smokers and former smokers; however, among men who never 
smoked, a trend of decreased risk was observed.[15] Similarly, a 
recent systematic review of epidemiological studies in Japan on 
green tea consumption and gastric cancer indicated no overall 
preventive effect of green tea in cohort studies; however, a small 
consistent risk reduction was found in women (but not in males 
because many men were smokers). When the results of all six 
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studies were combined, there was a significant protective effect of 
tea drinking against stomach cancer in women who did not smoke 
cigarettes or drink alcohol.[16] These studies demonstrated that the 
cancer‑preventive activities of tea constituents can be manifested in 
humans. Nevertheless, the effect is mild and cannot be observed in 
people who smoke. Indeed, cigarette smoke is the dominant factor 
in causing or influencing the formation of many types of cancer.
Many intervention trials have been conducted with green tea, 
and some have found a beneficial effect of green tea polyphe‑
nols in preventing the development of cancer. For example, in a 
double‑blind Phase II trial in Italy, 30 men with high‑grade pros‑
tate intraepithelial neoplasia (PIN) were given 600 mg of green 
tea catechins daily for 12 months.[17] Only 1 patient developed 
prostate cancer, whereas 9 of the 30 patients with high‑grade PIN 
in the placebo group developed prostate cancer (statistically sig‑
nificant). In a recent study in Japan, in patients who had colorectal 
adenomas removed by polypectomy, supplementation of green 
tea extract (1.5 g/day) for 12 months was shown to reduce the 
development of metachronous colorectal adenomas compared 
to a group of patients who did not take green tea extract.[18] The 
results of these studies are promising and would have a large 
impact if they could be reproduced in trials with larger numbers 
of subjects. More than 30 human trials with green tea polyphenol 
preparations are ongoing in the US, China, and Japan [National 
Institutes of Health (NIH) clinical trials; website http://cancer.
gov/clinicaltrials]. Some of these studies may yield clear con‑
clusions concerning the cancer‑preventive activities of green 
tea polyphenols.
The molecular mechanisms for cancer prevention by tea con‑
stituents have been extensively studied and reviewed.[4,5] The anti‑
oxidant actions of tea catechins could be an important mechanism 
for cancer prevention. Other well‑discussed mechanisms involve 
the binding of EGCG to target proteins, leading to the inhibition 
of metabolic or signal transduction pathways.[4,5]
WEIGHT REDUCTION AND ALLEVIATION 
OF METABOLIC SYNDROME
MetS is a complex of symptoms that include elevated waist 
circumference and two or more of the following: Elevated serum 
triglyceride, dysglycemia, elevated blood pressure, and reduced 
high‑density lipoprotein–associated cholesterol.[19] The effects 
of green tea (綠茶 Lǜ Chá) consumption on body weight and 
MetS have been studied extensively in animal models, and this 
topic was reviewed recently.[20] Most of the results showed that 
consumption of green tea extracts or EGCG significantly reduced 
weight gain and/or adipose tissue weight, reduced blood glucose 
or insulin levels, and increased insulin sensitivity or glucose 
tolerance.[20] In our studies, mice fed a high‑fat diet (60% of 
the total caloric intake) containing EGCG (3.2 g/kg diet) for 
16 weeks had significantly reduced body weight gain, percent 
body fat, hepatic steatosis, and visceral fat weight, as compared 
to mice without EGCG treatment.[21] These results were also 
reproduced in a second study using a high‑fat/Western style 
diet (60% of the calories from fat with low levels of calcium, 
vitamin D, folic acid, choline bitartrate, and fiber).[22] EGCG 
treatment also attenuated insulin resistance, plasma cholesterol 
levels, and monocyte chemoattractant protein concentrations 
in mice on the high‑fat diet.[21,22] Tea catechins have also been 
shown to reduce hepatic steatosis and liver toxicity in rodents 
treated with ethanol, tamoxifen, endotoxins, and liver ischemia/
reperfusion injury (reviewed in[20]).
Overall, these studies in animal models are very impressive. 
The modulation of the activities of specific enzymes and the 
expression of specific genes, such as those involved in gluconeo‑
genesis, fatty acid synthesis and degradation, and glucose trans‑
port, by tea polyphenols are intriguing.[23‑27] Some of the effects 
were produced by rather high doses of green tea polyphenols. It 
is not known whether these activities are exerted by tea catechins 
directly or indirectly through body weight reduction or through 
energy‑sensing proteins such as AMP activated kinases (AMPK).
The effects of tea on body weight in humans have been studied 
in many small, randomized controlled trials (RCTs) and the results 
have been reviewed.[28,29] Most of these studies observed a decrease 
of body weight or body fat due to daily consumption of four or 
more cups of green tea or 600‑900 mg of tea polyphenols.[28‑30] 
The role of caffeine in these studies was inconsistent among the 
different studies.[31] Several human studies have also provided 
evidence that tea drinking could ameliorate features of MetS and 
the subsequent risk for type 2 diabetes.[32] A cross‑sectional study 
of US adults showed that hot (brewed) tea, but not iced tea, intake 
was inversely associated with obesity and decreased biomarkers 
of MetS and CVDs.[33] A study of elderly male Taiwan residents 
in a rural community also indicated that tea drinking, especially 
by individuals who had drank 240 ml or more of tea daily, was 
inversely associated with MetS.[34] There is evidence from some, 
but not all, human studies that tea consumption (3‑6 cups per day) 
is associated with a reduced risk of type 2 diabetes.[28,35,36]
TEA AND CARDIOVASCULAR DISEASES 
PREVENTION
There have been many human studies about tea and CVDs, and 
this topic has been reviewed recently.[37,38] The strongest evidence 
for the reduction of CVD risk by the consumption of green tea 
(綠茶 Lǜ Chá) is provided by large cohort studies in Japan. In the 
first study, daily consumption of 1‑2 to >5 cups of tea was found 
to reduce death due to CVDs,[39] but in another study, consump‑
tion of >6 cups of tea daily seemed to result in a reduced CVD 
mortality rate.[40] This discrepancy reflects the lack of preciseness 
of epidemiological studies. A case–control study in China also 
showed a correlation between consumption of green or oolong 
tea and a decreased risk of ischemic stroke.[41] Many, but not all, 
studies in the US and Europe demonstrated an inverse associa‑
tion between black tea (紅茶 Hóng Chá) consumption and CVD 
risk.[37] Apparently, lifestyle and socioeconomic status may have 
confounded the results of many studies.[37] The quantity and types 
of tea consumed are also key factors for prevention of CVDs. In a 
recent meta‑analysis of 13 articles on the effects of green tea and 
black tea on the risk of coronary artery diseases, consumption of 
green tea, but not black tea, was found to be beneficial.[42]
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NEUROPROTECTIVE EFFECTS OF TEA
The loss of cognitive function due to the loss of structure and 
function of neuronal cells is a common process in neurodegen‑
erative diseases including Alzheimer disease (AD), Parkinson’s 
disease (PD), and Huntington’s disease.[43] Many epidemiological 
studies have suggested that tea drinking is associated with the 
improvement of cognitive function. Several studies have described 
a moderate risk reduction of PD in tea drinkers. A meta‑analysis 
covering 11 case–control and 1 cohort study concluded that tea 
consumption could protect against PD, especially in Chinese 
populations.[2] A recent meta‑analysis also supported the conclu‑
sion that tea drinking can lower the risk of PD.[44] Tea drinking was 
also associated with lowering the risks of depressive symptoms[45] 
and psychological distress.[46]
The characteristic amino acid theanine, which can cross the 
blood–brain barrier, is considered to be an important compound for 
the neuroprotective actions of tea. Theanine has been investigated 
for the treatment of anxiety, depression, stress, insomnia, sleep 
disturbance, and some schizophrenic symptoms. Several studies 
indicated that theanine relieved anxiety symptoms in patients with 
schizophrenic and schizoaffective disorders,[29] and a combination 
of green tea (綠茶 Lǜ Chá) extract and theanine improved memory 
and attention in subjects with mild cognitive impairments.[10,40] 
Theanine was also effective in improving sleep quality in boys 
diagnosed with attention deficit hyperactivity disorder.[10]
MECHANISTIC CONSIDERATIONS
The possible common mechanisms for the prevention of many 
diseases as discussed above are summarized in Figure 2. The an‑
tioxidant actions of tea polyphenols are likely to be important in 
the prevention of cancer and CVDs and in the alleviation of the 
inflammation in obesity and MetS. Decreased absorption of lipids 
and proteins appears to be a major mechanism for body weight 
reduction,[21,47] which also proves beneficial against MetS, diabetes, 
and CVDs. The effects of catechins (such as EGCG) on specific 
enzymes, transporters, receptors, and signaling molecules[5,23‑27] are 
interesting topics for further investigation. How a molecule such as 
EGCG could specifically affect the expression of different genes 
is intriguing and also requires further investigation.
Bioavailability is an important issue in determining the bio‑
logical effects of tea polyphenols in internal organs. This factor 
could explain some of the results that many of the beneficial ef‑
fects were observed with green tea (綠茶 Lǜ Chá) but not with 
black tea (紅茶 Hóng Chá), because the black tea polyphenols, 
theaflavins and thearubigins, are practically not bioavailable. Tea 
polyphenols such as EGCG, theaflavins, and thearubigins, which 
are not absorbed into the blood, may exert their effects in the 
gastrointestinal tract by decreasing lipid and protein absorption or 
affecting intestinal receptors. This is probably why black tea is also 
effective in lowering body weight, body fat, and blood cholesterol 
levels. The intestinal microbiota is known to degrade green tea 
polyphenols.[10] Some of the metabolites may have interesting 
biological activities. The degradation of theaflavins (from black 
tea) by gut microbes has been reported,[48] and more research on the 
microbial metabolism of tea constituents is needed. Tea consump‑
tion has been shown to affect intestinal microorganisms, in general, 
in favor of the growth of microbes that are beneficial to human 
health.[49,50] Additional research on the effects of tea consumption 
on gut microbiota may provide more information relating to body 
weight reduction and diabetes.
CONCLUDING REMARKS
As discussed above, the possible beneficial health effects 
of tea consumption in the prevention of chronic diseases have 
been suggested by many laboratory studies and epidemiological 
studies. Lack of beneficial effects of green tea (綠茶 Lǜ Chá) 
consumption observed in some human studies could be due to 
the lower quantities of tea consumed. Shall we increase our tea 
consumption to harness the possible beneficial health effects? 
Caution should be applied in the use of high quantities of tea 
for disease prevention. Gastrointestinal irritation caused by the 
ingestion of tea, especially with an empty stomach, has been ex‑
perienced by many people. Some experts on TCM indicated that 
ginger may alleviate such a probleme. Is this true? What is the 
physiological basis of such an interaction? In Ben Cao Gang Mu 
(本草綱目 Běn Cǎo Gāng Mù), Li Shizhen (李時珍 Lǐ Shí Zhēn) 
gives a very detailed description about the symptoms: “Long term 
consumption of tea by individuals with weak body and blood will 
cause severe irritation of the stomach and spleen…”c. This is a 
topic that warrants further studies. Hepatotoxicity in individuals 
consuming high doses of green tea extracts in dietary supplements 
for the purpose of weight reduction has been well documented.[1]
The possible health benefits of tea consumption as discussed 
in this review are important public health issues. The protection 
against some chronic diseases has been reported in individuals with 
daily consumption of four, five, or more cups of tea. The effects of 
lower levels of tea consumption (1‑3 cups per day) may be subtle, 
but could be additive to other plant‑based food or beverages. In 
Figure 2. The proposed mechanisms by which tea constituents (polyphenols, 
caffeine, and theanine) prevent chronic diseases. ROS: Reactive oxygen 
species; MetS: Metabolic syndrome; CVDs: Cardiovascular disease; 
NDDs: Neurodegenerative diseases (from [1])
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comparison to other beverages, such as sugary or non‑sugary soft 
drinks or ready‑made tea drinks, freshly brewed green or black 
tea (紅茶 Hóng Chá), consumed without added sugar, appears to 
be a healthier beverage.
FOOTNOTES
a  唐代陸羽《茶經》
b  唐代的《新修本草》，該書將茶列於木部中品, 言其味甘,苦, 
性微寒, 無毒, 其功效有下氣, 去痰, 熱, 渴, 令人少睡, 消宿
  食, 利小便, 治瘺瘡等。
c  李時珍《本草綱目》：“茶苦而寒，陰中之陰，沉也，
降也，最為降火。火為百病…”
d  如虛寒及血弱之人，飲之既久, 則脾胃惡寒, 元氣暗損,土
不制水, 精血潛虛, 成痰飲, 成痞脹, 成痿痺，成黃瘦，成嘔
  逆，成洞瀉，成腹痛，成疝瘕，種種內傷，此茶之害
也。民生日用, 蹈其弊者, 往往皆是, 而婦嫗受害更多, 習
俗移人，自不覺爾。
e  Personal communications from Professor Lee‑Yan Sheen, 
National Taiwan University.
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